On 3-5 June, IFPMA joined the 3rd @g20org Health Working Group meeting in Hyderabad, India and brought the innovative pharma industry's perspectives on #G20 global health priorities.
⬇️Read this thread to find out more
On 3 June, we attended an event on the "Global Vaccine Research Collaborative,” stressing our commitment to the #100DaysMission.
We stated that the Health Emergencies Prevention, Preparedness & Response (#HEPPR) includes duplicative and fragmented proposals, which are not fit-for-purpose for the private sector.
To strengthen cooperation in the pharmaceutical sector with a focus on safe, effective & affordable medical countermeasures, it is 🔑to include our industry in all discussions on global health architecture.
🗓️Today, IFPMA is hosting a platform to explore the different types of partnerships that supported the manufacturing scale-up of vaccines & treatments during #COVID19.
Delighted to welcome companies who partnered to deliver #COVID19#vaccines & treatments to share experiences of voluntary licensing, tech transfer & other collaborations.
Discussion explores the frameworks that allowed them to take place.